DeutschNewstral
Article
jdsupra.com on 2023-07-14 19:15
CMS Announces Proposed $9 Billion Remedy for Hospitals Underpaid by Unlawful Rate Cut for 340B Drugs
Related news
- CMS Issues Proposed Remedy for 340B-Acquired Drug Payment Policyjdsupra.com
- CMS to survey hospitals about acquisition costs for 340B drugsjdsupra.com
- CMS Proposes More Payment Changes for 340B Hospitals in 2019jdsupra.com
- CMS Reverses 340B Payment Cuts for 2023 but Does Not Address Remedy for Prior Yearsjdsupra.com
- CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022jdsupra.com
- CMS Giveth and Taketh Away: The Long-Term Impact of the 340B Remedy Policyjdsupra.com
- Policy Update - CMS Finalizes Remedy for 340B-Acquired Drugs Purchased in CYs 2018–2022jdsupra.com
- Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policyjdsupra.com
- CMS Ignores the Courts: 2020 Hospital Outpatient Prospective Payment System Final Rule Includes 340B Rate Cuts Already Ruled Unlawfuljdsupra.com
- Court Rules on Retrospective Relief for 340B Hospitals Without Vacating CMS’s Rulesjdsupra.com
- CMS restores 340B drug acquisition reimbursementjdsupra.com
- CMS expands reimbursement cuts on 340B drugsjdsupra.com
- CMS Proposes Reimbursement Reduction for 340B Drugsjdsupra.com
- Supreme Court Overturns Medicare Outpatient Drug Rate Cut for 340B Hospitalsjdsupra.com
- 340B Remedy Rule and Medicare Advantage Rates: Navigating Shifting Paymentsjdsupra.com
- 340B Rate Cuts Reversed by CMS for 2023jdsupra.com
- CMS Finalizes 340b Payment Provisions in 2023 OPPS Final Rulejdsupra.com
- 340B Update: Appellate Court Upholds 340B Payment Reduction as CMS Proposes Further Reductions for 2021jdsupra.com
- 340B Medicare Reimbursement Cuts Ruled Unlawful by Supreme Courtjdsupra.com
- 340B Update: CMS Seeks Comments on Acquisition Cost Data Surveyjdsupra.com